Effect of orally administered silver nanoparticles on histological alterations in Wistar rats
DOI:
https://doi.org/10.48165/jvls.2025.1.1.5Keywords:
Nanosilver, NOAEL dose, Pathology, Wistar ratsAbstract
The present study aimed to evaluate the histopathological effects of orally administered silver nanoparticles (AgNPs) at the No-Observed-Adverse-Effect Level (NOAEL) in Wistar rats over a 90 days period. Thirty-five healthy, six-weeks-old Wistar rats of both sexes were randomly divided into two groups: Group I (control, n=20) and Group II (treatment, n=15). Rats in Group II received AgNPs suspended in distilled water at a NOAEL dose of 30 mg/ kg body weight/day via oral gavage for 90 consecutive days. Five rats from each group were sacrificed at 0 (only from Group I), 30th, 60th, and 90th days post-treatment (DPT), and tissue samples were collected for gross and histopathological examination. No lesions were observed in any organs of the control group throughout the study. In contrast, treated rats exhibited gross lesions such as red patches on the liver, discoloration in the lungs, and mild cardiac congestion. Histologically, the liver showed congestion, thrombus formation, and hepatocellular degeneration; lungs revealed thickened interalveolar walls, emphysema, congestion, and increased mononuclear cell infiltration. Kidneys demonstrated congestion, interstitial hemorrhages, and coagulative necrosis of tubular epithelial cells. Other organs including the spleen, uterus, and testis did not show any significant lesions. These findings indicate that chronic oral exposure to nanosilver, even at NOAEL levels, can induce adverse histopathological changes in vital organs of Wistar rats.
Downloads
References
Al Gurabi, M. A., Ali, D., Alkahtani, S., & Alarifi, S. (2015). In vivo DNA damaging and apoptotic potential of silver nanoparticles in Swiss albino mice. OncoTargets and Therapy, 8, 295–302.
Almansour, M., Jarrar, Q., Battah, A., & Jarrar, B. (2015). Morphometric alterations induced by toxicity of different sizes of silver nanoparticles. International Journal of Morphology, 33(2), 544–552.
Bahadar, H., Maqbool, F., Niaz, K., & Abdollahi, M. (2016). Toxicity of nanoparticles and overview of current experimental models. Iranian Biomedical Journal, 20(1), 1–11.
Baldi, C., Minoia, C., Di Nucci, A., Capodaglio, E., & Manzo, L. (1988). Effects of silver in isolated rat hepatocytes. Toxicology Letters, 41, 261–269.
Choudhary, A., Singh, S., & Ravichandiran, V. (2022). Toxicity, preparation methods, and applications of silver nanoparticles: An update. Toxicology Mechanisms and Methods, 32(9), 650–661.
Drake, P. L., & Hazelwood, K. J. (2005). Exposure-related health effects of silver and silver compounds: A review. Annals of Occupational Hygiene, 49(7), 575–585.
Ema, M., Kobayashi, N., Naya, M., Hanai, S., & Nakanishi, J. (2010). Reproductive and developmental toxicity of manufactured nanomaterials. Reproductive Toxicology, 30(3), 343–352.
Kim, S., Choi, J. E., Choi, J., Chung, K. H., Park, K., Yi, J., & Ryu, D. Y. (2009). Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicology In Vitro, 23(6), 1076–1084.
Kim, Y. S., Kim, J. S., Cho, H. S., Rha, D. S., Kim, J. M., Park, J. D., & Yu, I. J. (2008). Oral toxicity and tissue distribution of silver nanoparticles in rats. Inhalation Toxicology, 20(6), 575–583.
Kim, Y. S., Song, M. Y., Park, J. D., Song, K. S., Ryu, H. R., Chung, Y. H., & Yu, I. J. (2010). Subchronic oral toxicity of silver nanoparticles. Particle and Fibre Toxicology, 7(1), 1–11.
Luna, L. G. (1968). Manual of histopathological staining methods of the Armed Forces Institute of Pathology (3rd ed.). McGraw-Hill.
Martínez-Cisterna, D., Rubilar, O., Tortella, G., Chen, L., Chacón-Fuentes, M., Lizama, M., Parra, P., & Bardehle, L. (2024). Silver nanoparticles as nanopesticides: Toxic effects and mechanisms. Molecules, 29(23), 5520–5528.
Natsuki, J., Natsuki, T., & Hashimoto, Y. (2015). Silver nanoparticles: Synthesis methods, properties, and applications. International Journal of Materials Science and Applications, 4(5), 325–332.
Skalska, J., & Strużyńska, L. (2015). Toxic effects of silver nanoparticles in mammals: Neurotoxicity risks. Folia Neuropathologica, 53(4), 281–300.
Sulaiman, F. A., Adeyemi, O. S., Akanji, M. A., Oloyede, H. O. B., Sulaiman, A. A., Olatunde, A., & Salawu, M. O. (2015). Biochemical and morphological alterations caused by silver nanoparticles in Wistar rats. Journal of Acute Medicine, 5(4), 96–102.
Wang, F., Zhou, L., Mu, D., Zhang, H., Zhang, G., Huang, X., & Xiong, P. (2024). Ecotoxicity of metal-based nanoparticles: Exposure pathways and mechanisms. Frontiers in Public Health, 12, 1390099.
Wiemann, M., Vennemann, A., Blaske, F., Sperling, M., & Karst, U. (2017). Silver nanoparticles in the lung: Toxic effects and accumulation. Nanomaterials, 7(12), 441.
Yang, S. T., Wang, X., Jia, G., Gu, Y., Wang, T., Nie, H., & Liu, Y. (2008). Long-term accumulation and toxicity of carbon nanotubes in mice. Toxicology Letters, 181(3), 182–189.
Zhang, J., & Saltzman, W. M. (2013). Engineering biodegradable nanoparticles for drug and gene delivery. Chemical Engineering Progress, 109, 25–30.
